These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37310396)

  • 21. FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.
    Seshacharyulu P; Rachagani S; Muniyan S; Siddiqui JA; Cruz E; Sharma S; Krishnan R; Killips BJ; Sheinin Y; Lele SM; Smith LM; Talmon GA; Ponnusamy MP; Datta K; Batra SK
    Oncogene; 2019 Jun; 38(26):5265-5280. PubMed ID: 30914801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease.
    Patil NY; Rus I; Downing E; Mandala A; Friedman JE; Joshi AD
    J Pharmacol Exp Ther; 2022 Oct; 383(1):32-43. PubMed ID: 35933113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis.
    Uehara K; Sostre-Colón J; Gavin M; Santoleri D; Leonard KA; Jacobs RL; Titchenell PM
    Cell Mol Gastroenterol Hepatol; 2022; 13(6):1625-1647. PubMed ID: 35240344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats.
    Luo H; Xu N; Wu J; Gan Y; Chen L; Guan F; Li M; Li Y; Chen J; Su Z; Liu Y
    Int Immunopharmacol; 2021 Sep; 98():107915. PubMed ID: 34198236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.
    Iacobini C; Menini S; Ricci C; Blasetti Fantauzzi C; Scipioni A; Salvi L; Cordone S; Delucchi F; Serino M; Federici M; Pricci F; Pugliese G
    J Hepatol; 2011 May; 54(5):975-83. PubMed ID: 21145823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An enzyme-coupled continuous fluorescence assay for farnesyl diphosphate synthases.
    Dozier JK; Distefano MD
    Anal Biochem; 2012 Feb; 421(1):158-63. PubMed ID: 22085443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice.
    Rajak S; Tewari A; Raza S; Gupta P; Chakravarti B; Anjum B; Tripathi M; Singh BK; Yen PM; Goel A; Ghosh S; Sinha RA
    Biochim Biophys Acta Mol Basis Dis; 2023 Apr; 1869(4):166662. PubMed ID: 36754244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise training suppresses scavenger receptor CD36 expression in kupffer cells of nonalcoholic steatohepatitis model mice.
    Kawanishi N; Mizokami T; Yada K; Suzuki K
    Physiol Rep; 2018 Dec; 6(23):e13902. PubMed ID: 30516003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH).
    Utsunomiya H; Yamamoto Y; Takeshita E; Tokumoto Y; Tada F; Miyake T; Hirooka M; Abe M; Kumagi T; Matsuura B; Ikeda Y; Hiasa Y
    J Gastroenterol; 2017 Aug; 52(8):940-954. PubMed ID: 28062946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
    Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
    [No Abstract]   [Full Text] [Related]  

  • 31. Farnesyl diphosphate synthase, the target for nitrogen-containing bisphosphonate drugs, is a peroxisomal enzyme in the model system Dictyostelium discoideum.
    Nuttall JM; Hettema EH; Watts DJ
    Biochem J; 2012 Nov; 447(3):353-61. PubMed ID: 22849378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.
    Tanaka N; Takahashi S; Zhang Y; Krausz KW; Smith PB; Patterson AD; Gonzalez FJ
    Biochim Biophys Acta; 2015 Jul; 1852(7):1242-52. PubMed ID: 25736301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic CDP-diacylglycerol synthase 2 deficiency causes mitochondrial dysfunction and promotes rapid progression of NASH and fibrosis.
    Xu J; Chen S; Wang W; Man Lam S; Xu Y; Zhang S; Pan H; Liang J; Huang X; Wang Y; Li T; Jiang Y; Wang Y; Ding M; Shui G; Yang H; Huang X
    Sci Bull (Beijing); 2022 Feb; 67(3):299-314. PubMed ID: 36546079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36.
    Zhang H; Li Y; Zhang C; Huang K; Zhao J; Le S; Jiang L; Liu H; Yang P; Xiao X; Yu J; Wu J; Ye P; Xia J
    Cell Death Dis; 2022 Apr; 13(4):359. PubMed ID: 35436984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH).
    Li X; Ding K; Li X; Yuan B; Wang Y; Yao Z; Wang S; Huang H; Xu B; Xie L; Deng T; Chen XW; Chen Z
    Nat Commun; 2022 Aug; 13(1):4549. PubMed ID: 35927268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
    Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
    Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
    Rada P; González-Rodríguez Á; García-Monzón C; Valverde ÁM
    Cell Death Dis; 2020 Sep; 11(9):802. PubMed ID: 32978374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking integrin α
    Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
    J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells.
    Ishimoto K; Tachibana K; Hanano I; Yamasaki D; Nakamura H; Kawai M; Urano Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Doi T
    Biochem J; 2010 Jul; 429(2):347-57. PubMed ID: 20450493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma.
    Abate M; Laezza C; Pisanti S; Torelli G; Seneca V; Catapano G; Montella F; Ranieri R; Notarnicola M; Gazzerro P; Bifulco M; Ciaglia E
    Sci Rep; 2017 Oct; 7(1):14123. PubMed ID: 29075041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.